Abstract
Ethanol inhibits L-type Ca++ channels, but little is known about its effect on other voltage-gated Ca++ channels. To examine non-L-type channels we used nerve growth factor-differentiated PC12 cells treated with the L channel blocker nifedipine. Using selective Ca++ channel antagonists, we found that N-type and P/Q -type channels mediate most of the remaining depolarization-evoked Ca++ rise. Ethanol (10–150 mM) inhibited depolarization-induced rises in intracellular Ca++ with maximal inhibition of 46% achieved using 50 mM ethanol. Inhibition was time dependent, requiring at least 8 min to develop fully. Ethanol did not alter Ca++ mobilization, sequestration, extrusion or capacitative entry. Sp-adenosine cyclic 3′,5′-phosphorothioate, a specific activator of protein kinase A (PKA), blocked inhibition by ethanol, whereas the protein kinase C activator phorbol 12-myristate, 13-acetate did not. Okadaic acid, an inhibitor of protein phosphatases type-1 and type-2A, also blocked inhibition by ethanol with an IC50 of 3 nM. This was prevented by inhibiting PKA, indicating that the action of okadaic acid was due to increased PKA-mediated phosphorylation. These results indicate that ethanol can inhibit N-type and P/Q-type channels and this is antagonized by activating PKA. The findings suggest the sensitivity of these channels to ethanol is regulated by a phosphoprotein that is a substrate for PKA and protein phosphatase type-2A.
Footnotes
-
Send reprint requests to: Dr. Robert O. Messing, Building 1, Room 101, 1001 Potrero Avenue, San Francisco, CA 94110.
-
↵1 This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism and the Alcoholic Beverage Medical Research Foundation (R.O.M.).
- Abbreviations:
- PKA
- protein kinase A
- PKC
- protein kinase C
- GABA
- γ-aminobutyric acid
- AMPA
- α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
- Sp-cAMPS
- Sp-adenosine cyclic 3′, 5′-phosphorothioate
- Rp-cAMPS
- Rp-adenosine cyclic 3′, 5′-phosphorothioate
- DMEM
- Dulbecco’s modified Eagle’s medium
- cAMP
- cyclic adenosine monophosphate
- EGTA
- ethylene glycol bis(β-aminoethyl ester)-N, N′-tetraacetic acid
- HEPES
- N-[2-hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid]
- [Ca2+]i
- intracellular calcium concentration
- PP-1 protein phosphatase type-1
- PP-2A, protein phosphatase type-2A
- PP-2B
- protein phosphatase type-2B
- Received March 4, 1997.
- Accepted May 23, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|